Detalles de la búsqueda
1.
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.
Support Care Cancer
; 29(11): 6903-6912, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023950
2.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971318
3.
Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery.
Curr Oncol
; 31(5): 2488-2496, 2024 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785467
4.
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care.
Curr Oncol
; 31(3): 1376-1388, 2024 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534937
5.
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective.
Curr Oncol
; 30(12): 10477-10487, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132397
6.
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape.
Curr Oncol
; 31(1): 145-167, 2023 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38248095
7.
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets.
JCO Clin Cancer Inform
; 7: e2300116, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011617
8.
The phosphatidylinositol 4-kinase PI4KIIIalpha is required for the recruitment of GBF1 to Golgi membranes.
J Cell Sci
; 123(Pt 13): 2273-80, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530568
9.
Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective.
Curr Oncol
; 29(6): 4125-4137, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735438
10.
Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status.
Curr Oncol
; 29(1): 383-391, 2022 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35049708
11.
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?
Curr Oncol
; 28(4): 2523-2528, 2021 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287262
12.
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey.
Curr Oncol
; 29(1): 1-13, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35049675
13.
De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis.
Cancer Treat Rev
; 99: 102254, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34242928
14.
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey.
Curr Oncol
; 28(6): 5215-5226, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940075
15.
An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma.
Eur Urol Focus
; 6(1): 34-36, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010693
16.
Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer.
Am Soc Clin Oncol Educ Book
; 39: e8-e21, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099662
17.
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.
Breast Cancer
; 25(4): 479-488, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29470723
Resultados
1 -
17
de 17
1
Próxima >
>>